Snyder, Robert W., M.d., Ph.d., P.c.
Clinical trials sponsored by Snyder, Robert W., M.d., Ph.d., P.c., explained in plain language.
-
Parkinson's pill tested to halt leading cause of blindness
Disease control CompletedThis study tested whether carbidopa-levodopa, a common Parkinson's disease medication, could help control 'wet' age-related macular degeneration (AMD), a major cause of vision loss. Researchers gave the oral medication to 20 participants with newly diagnosed wet AMD to see if it …
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Parkinson's drug tested as potential Game-Changer for blinding eye disease
Disease control CompletedThis study tested if taking carbidopa-levodopa pills (a medication used for Parkinson's disease) for a full year could help control 'wet' age-related macular degeneration (AMD), a leading cause of vision loss. It was a 9-month extension for 35 people who had already completed a 3…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Parkinson's drug tested as potential new weapon against leading cause of blindness
Disease control CompletedThis study tested whether a common Parkinson's disease pill (carbidopa-levodopa) could help people with 'wet' age-related macular degeneration (AMD), a major cause of vision loss. Researchers gave the drug to 35 participants who were also receiving standard eye injections, to see…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC